Creative Biolabs-Immuno-oncology

Anti-DLL3 (clone SC1G6Z.5L6Z) SynExpress E1-BF-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR2132)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLL3 (clone SC1G6Z.5L6Z). We employs the Retrovirus (EF1α-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
DLL3
Clone
SC1G6Z.5L6Z
Species Reactivity
Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.95
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.